Literature DB >> 27816493

The HCV care continuum does not end with cure: A call to arms for the prevention of reinfection.

Oluwaseun Falade-Nwulia1, Mark Sulkowski2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27816493      PMCID： PMC5472097          DOI： 10.1016/j.jhep.2016.10.027

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  12 in total

1.  Hepatitis C reinfection after sustained virological response.

Authors:  Håvard Midgard; Benedikte Bjøro; Arild Mæland; Zbigniew Konopski; Hege Kileng; Jan K Damås; Jørn Paulsen; Lars Heggelund; Per K Sandvei; Jetmund O Ringstad; Lars N Karlsen; Kathrine Stene-Johansen; John H-O Pettersson; Dagny H Dorenberg; Olav Dalgard
Journal:  J Hepatol       Date:  2016-01-11       Impact factor: 25.083

2.  Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM.

Authors:  Femke A E Lambers; Maria Prins; Xiomara Thomas; Richard Molenkamp; David Kwa; Kees Brinkman; Jan T M van der Meer; Janke Schinkel
Journal:  AIDS       Date:  2011-11-13       Impact factor: 4.177

Review 3.  Incidence of sexually transmitted hepatitis C virus infection in HIV-positive men who have sex with men.

Authors:  Holly Hagan; Ashly E Jordan; Joshua Neurer; Charles M Cleland
Journal:  AIDS       Date:  2015-11       Impact factor: 4.177

4.  HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe.

Authors:  Patrick Ingiliz; Thomas C Martin; Alison Rodger; Hans-Jürgen Stellbrink; Stefan Mauss; Christoph Boesecke; Mattias Mandorfer; Julie Bottero; Axel Baumgarten; Sanjay Bhagani; Karine Lacombe; Mark Nelson; Jürgen K Rockstroh
Journal:  J Hepatol       Date:  2016-09-17       Impact factor: 25.083

5.  The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugs.

Authors:  Margaret Hellard; David A Rolls; Rachel Sacks-Davis; Garry Robins; Philippa Pattison; Peter Higgs; Campbell Aitken; Emma McBryde
Journal:  Hepatology       Date:  2014-10-24       Impact factor: 17.425

6.  Can Hepatitis C Virus (HCV) Direct-Acting Antiviral Treatment as Prevention Reverse the HCV Epidemic Among Men Who Have Sex With Men in the United Kingdom? Epidemiological and Modeling Insights.

Authors:  Natasha K Martin; Alicia Thornton; Matthew Hickman; Caroline Sabin; Mark Nelson; Graham S Cooke; Thomas C S Martin; Valerie Delpech; Murad Ruf; Huw Price; Yusef Azad; Emma C Thomson; Peter Vickerman
Journal:  Clin Infect Dis       Date:  2016-02-16       Impact factor: 9.079

Review 7.  Risk of Late Relapse or Reinfection With Hepatitis C Virus After Achieving a Sustained Virological Response: A Systematic Review and Meta-analysis.

Authors:  Bryony Simmons; Jawaad Saleem; Andrew Hill; Richard D Riley; Graham S Cooke
Journal:  Clin Infect Dis       Date:  2016-01-19       Impact factor: 9.079

8.  Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventions.

Authors:  Luisa Salazar-Vizcaya; Roger D Kouyos; Cindy Zahnd; Gilles Wandeler; Manuel Battegay; Katharine Elizabeth Anna Darling; Enos Bernasconi; Alexandra Calmy; Pietro Vernazza; Hansjakob Furrer; Matthias Egger; Olivia Keiser; Andri Rauch
Journal:  Hepatology       Date:  2016-10-19       Impact factor: 17.425

9.  Hepatitis C virus reinfection incidence and treatment outcome among HIV-positive MSM.

Authors:  Thomas C S Martin; Natasha K Martin; Matthew Hickman; Peter Vickerman; Emma E Page; Rhiannon Everett; Brian G Gazzard; Mark Nelson
Journal:  AIDS       Date:  2013-10-23       Impact factor: 4.177

10.  HIV-infected men who have sex with men who identify themselves as belonging to subcultures are at increased risk for hepatitis C infection.

Authors:  Amy Matser; Joost Vanhommerig; Maarten F Schim van der Loeff; Ronald B Geskus; Henry J C de Vries; Jan M Prins; Maria Prins; Sylvia M Bruisten
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240
View more
  8 in total

1.  Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.

Authors:  Madeleine C Mankowski; Valerie J Kinchen; Lisa N Wasilewski; Andrew I Flyak; Stuart C Ray; James E Crowe; Justin R Bailey
Journal:  Proc Natl Acad Sci U S A       Date:  2017-12-18       Impact factor: 11.205

2.  Plasma deconvolution identifies broadly neutralizing antibodies associated with hepatitis C virus clearance.

Authors:  Valerie J Kinchen; Guido Massaccesi; Andrew I Flyak; Madeleine C Mankowski; Michelle D Colbert; William O Osburn; Stuart C Ray; Andrea L Cox; James E Crowe; Justin R Bailey
Journal:  J Clin Invest       Date:  2019-08-13       Impact factor: 14.808

3.  Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework.

Authors:  Stephanie Popping; Manal El-Sayed; Jordan Feld; Angelos Hatzakis; Margaret Hellard; Olufunmilayo Lesi; Michael Ninburg; John Ward; Charles Boucher
Journal:  J Virus Erad       Date:  2018-07-01

4.  Validation of a questionnaire to monitor symptoms in HIV-infected patients during hepatitis C treatment.

Authors:  Edward R Cachay; Craig Ballard; Bradford Colwell; Francesca Torriani; Charles Hicks; Wm Christopher Mathews
Journal:  AIDS Res Ther       Date:  2017-09-20       Impact factor: 2.250

5.  Differences across cyclophilin A orthologs contribute to the host range restriction of hepatitis C virus.

Authors:  Jenna M Gaska; Metodi Balev; Qiang Ding; Brigitte Heller; Alexander Ploss
Journal:  Elife       Date:  2019-05-10       Impact factor: 8.140

6.  Hepatitis C risk perceptions and attitudes towards reinfection among HIV-diagnosed gay and bisexual men in Melbourne, Australia.

Authors:  Sophia E Schroeder; Peter Higgs; Rebecca Winter; Graham Brown; Alisa Pedrana; Margaret Hellard; Joseph Doyle; Mark Stoové
Journal:  J Int AIDS Soc       Date:  2019-05       Impact factor: 5.396

7.  Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C.

Authors:  Akira Nishio; Sharika Hasan; Heiyoung Park; Nana Park; Jordan H Salas; Eduardo Salinas; Lela Kardava; Paul Juneau; Nicole Frumento; Guido Massaccesi; Susan Moir; Justin R Bailey; Arash Grakoui; Marc G Ghany; Barbara Rehermann
Journal:  Nat Commun       Date:  2022-09-16       Impact factor: 17.694

8.  Development and Validation of an Electronic Medical Record-Based Algorithm to Identify Patient Milestones in the Hepatitis C Virus Care Cascade.

Authors:  Jason Zucker; Justin G Aaron; Daniel J Feller; Jacek Slowikowski; Henry Evans; Matthew L Scherer; Michael T Yin; Peter Gordon
Journal:  Open Forum Infect Dis       Date:  2018-07-03       Impact factor: 3.835
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.